Table 2.
Adverse cardiovascular events according to SIRI tertiles during follow-up.
| Adverse cardiovascular events | T1: <0.63 | T2: 0.63–1.02 | T3: >1.02 | p Value |
|---|---|---|---|---|
| MACE, n (%) | 73 (12.7) | 120 (20.8) | 162 (28.2) | <.001 |
| Overall death, n (%) | 3 (0.5) | 8 (1.4) | 35 (6.1) | <.001 |
| Non-fatal MI, n (%) | 10 (1.7) | 13 (2.3) | 26 (4.5) | .010 |
| Non-fatal stroke, n (%) | 2 (0.3) | 9 (1.6) | 14 (2.4) | .012 |
| URR, n (%) | 65 (11.3) | 104 (18.1) | 118 (20.6) | <.001 |
The MACE was defined as the composite of overall death, non-fatal stroke, non-fatal MI, and URR.
MACE: major adverse cardiovascular events; MI: myocardial infarction; URR: unplanned repeat revascularization.